7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 
      
    		            
      assets
    		            
      current assets:
    		            
      cash and cash equivalents
    		102,912,000 147,024,000 152,123,000 169,510,000 172,130,000 381,627,000 97,832,000 129,792,000 50,636,000 40,591,000 126,493,000 26,091,000 
      short-term investments
    		696,131,000 639,472,000 684,759,000 714,008,000 743,156,000 545,492,000 338,617,000 337,531,000 154,788,000 183,996,000 114,369,000 64,750,000 
      prepaid expenses and other current assets
    		14,979,000 12,802,000 12,740,000 7,693,000 8,365,000 10,502,000 12,911,000 6,285,000 4,535,000 3,635,000 5,293,000 2,248,000 
      total current assets
    		814,022,000 799,298,000 849,622,000 891,211,000 923,651,000 937,621,000 449,360,000 473,608,000 209,959,000 228,222,000 246,155,000 93,089,000 
      property and equipment
    		4,675,000 3,459,000 3,518,000 3,478,000 3,735,000 3,315,000 3,120,000 3,228,000 2,408,000 1,078,000 961,000 1,031,000 
      operating right-of-use assets
    		6,863,000 7,484,000 7,313,000 3,535,000 4,009,000 4,267,000 4,698,000 5,136,000 3,653,000 90,000 178,000 262,000 
      other non-current assets
    		6,599,000 6,202,000 6,096,000 5,106,000 1,822,000 1,826,000 47,000 45,000 350,000 38,000 59,000 3,463,000 
      total assets
    		832,159,000 816,443,000 866,549,000 903,330,000 933,217,000 947,029,000 457,225,000 482,017,000 216,370,000 229,428,000 247,353,000 97,845,000 
      liabilities and shareholders’ equity
    		            
      current liabilities:
    		            
      accounts payable
    		17,796,000 8,990,000 8,710,000 8,024,000 8,447,000 2,209,000 6,538,000 4,742,000 3,319,000 5,699,000 4,945,000 6,009,000 
      accrued expenses and other current liabilities
    		36,929,000 27,379,000 25,306,000 26,299,000 23,275,000 18,821,000 15,448,000 18,558,000 15,955,000 9,241,000 5,889,000 6,741,000 
      operating lease liabilities, current portion
    		2,802,000 2,664,000 2,471,000 1,698,000 1,712,000 1,629,000 1,600,000 1,440,000 817,000 73,000 168,000 260,000 
      total current liabilities
    		57,527,000 39,033,000 36,487,000 36,021,000 33,434,000 22,659,000 23,586,000 24,740,000 20,091,000 15,013,000 11,002,000 13,010,000 
      operating lease liabilities, net of current portion
    		4,288,000 5,012,000 5,116,000 2,164,000 2,673,000 3,045,000 3,525,000 4,013,000 3,034,000    
      other non-current liabilities
    		325,000 317,000 308,000 302,000 309,000 293,000 296,000 298,000 281,000    
      total liabilities
    		62,140,000 44,362,000 41,911,000 38,487,000 36,416,000 25,997,000 27,407,000 29,051,000 23,406,000 15,013,000 11,002,000 13,010,000 
      commitments and contingencies
    		            
      shareholders’ equity:
    		            
      undesignated shares – 0.0001 par value; 100,000 shares authorized as of september 30, 2025 and december 31, 2024
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of september 30, 2025 and december 31, 2024; 182,033 and 171,860 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
    		18,000            
      additional paid-in capital
    		1,272,480,000 1,209,294,000 1,199,737,000 1,193,010,000 1,186,564,000 1,180,144,000 662,502,000 659,003,000 375,332,000 373,001,000 371,120,000 1,921,000 
      accumulated other comprehensive income
    		825,000 362,000 815,000 914,000 2,839,000 -487,000 -90,000 521,000   147,000  
      accumulated deficit
    		-503,304,000 -437,592,000 -375,931,000 -329,098,000 -292,619,000 -258,642,000 -232,608,000 -206,572,000 -182,069,000 -158,207,000 -134,927,000 -116,952,000 
      total shareholders’ equity
    		770,019,000 772,081,000 824,638,000 864,843,000 896,801,000 921,032,000 429,818,000 452,966,000 192,964,000 214,415,000 236,351,000  
      total liabilities and shareholders’ equity
    		832,159,000 816,443,000 866,549,000 903,330,000 933,217,000 947,029,000 457,225,000      
      ​
    		           2,022,000 
      undesignated shares – 0.0001 par value; 100,000 shares authorized as of june 30, 2025 and december 31, 2024
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of june 30, 2025 and december 31, 2024; 172,700 and 171,860 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
    		 17,000           
      undesignated shares – 0.0001 par value; 100,000 shares authorized as of march 31, 2025 and december 31, 2024
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of march 31, 2025 and december 31, 2024; 172,610 and 171,860 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively
    		  17,000          
      undesignated shares – 0.0001 par value; 100,000 shares authorized as of december 31, 2024 and december 31, 2023
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of december 31, 2024 and december 31, 2023; 171,860 and 139,220 shares issued and outstanding as of december 31, 2024 and december 31, 2023, respectively
    		   17,000         
      undesignated shares – 0.0001 par value; 100,000 shares authorized as of september 30, 2024 and december 31, 2023
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of september 30, 2024 and december 31, 2023; 171,762 and 139,220 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively
    		    17,000        
      undesignated shares – 0.0001 par value; 100,000 shares authorized as of june 30, 2024 and december 31, 2023
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of june 30, 2024 and december 31, 2023; 171,589 and 139,220 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively
    		     17,000       
      undesignated shares – 0.0001 par value; 90,188 and 90,188 shares authorized as of march 31, 2024 and december 31, 2023, respectively
    		            
      ordinary shares – 0.0001 par value; 500,000 shares authorized as of march 31, 2024 and december 31, 2023; 139,855 and 139,220 shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively
    		      14,000      
      liabilities, redeemable convertible preferred shares and shareholders’ equity
    		            
      series a redeemable convertible preferred shares – 0.0001 par value, 0 and 19,200 shares authorized, issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
    		            
      series a+ redeemable convertible preferred shares – 0.0001 par value, 0 and 12,800 shares authorized, issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
    		            
      series b redeemable convertible preferred stock – 0.0001 par value, 0 and 32,857 shares authorized, issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
    		            
      series b‑1 redeemable convertible preferred stock – 0.0001 par value, 0 and 2,161 shares authorized, issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
    		            
      shareholders’ equity
    		            
      undesignated shares – 0.0001 par value; 90,188 and 0 shares authorized as of december 31, 2023 and december 31, 2022, respectively
    		            
      ordinary shares – 0.0001 par value; 500,000 and 432,982 shares authorized as of december 31, 2023 and december 31, 2022, respectively; 139,220 and 10,527 shares issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
    		       14,000     
      total liabilities, redeemable convertible preferred shares and shareholders’ equity
    		       482,017,000 216,370,000 229,428,000 247,353,000  
      series a redeemable convertible preferred shares – 0.0001 par value, 0 and 19,200 shares authorized, issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		            
      series a+ redeemable convertible preferred shares – 0.0001 par value, 0 and 12,800 shares authorized, issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		            
      series b redeemable convertible preferred stock – 0.0001 par value, 0 and 32,857 shares authorized, issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		            
      series b‑1 redeemable convertible preferred stock – 0.0001 par value, 0 and 2,161 shares authorized, issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		            
      undesignated shares – 0.0001 par value; 100,000 and 0 shares authorized as of september 30, 2023 and december 31, 2022, respectively
    		            
      non-voting ordinary shares – 0.0001 par value; 7,411 and 0 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		        1,000    
      ordinary shares – 0.0001 par value; 500,000 and 432,982 shares authorized as of september 30, 2023 and december 31, 2022, respectively; 107,723 and 10,527 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		        10,000    
      accumulated other comprehensive loss
    		        -310,000 -390,000  -110,000 
      series a redeemable convertible preferred shares – 0.0001 par value, 0 and 19,200 shares authorized, issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		            
      series a+ redeemable convertible preferred shares – 0.0001 par value, 0 and 12,800 shares authorized, issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		            
      series b redeemable convertible preferred stock – 0.0001 par value, 0 and 32,857 shares authorized, issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		            
      series b‑1 redeemable convertible preferred stock – 0.0001 par value, 0 and 2,161 shares authorized, issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		            
      undesignated shares – 0.0001 par value; 100,000 and 0 shares authorized as of june 30, 2023 and december 31, 2022, respectively
    		            
      non-voting ordinary shares – 0.0001 par value; 7,411 and 0 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		         1,000   
      ordinary shares – 0.0001 par value; 500,000 and 432,982 shares authorized as of june 30, 2023 and december 31, 2022, respectively; 107,387 and 10,527 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		         10,000   
      series a redeemable convertible preferred shares – 0.0001 par value, 0 and 19,200 shares authorized, issued and outstanding as of march 31, 2023 and december 31, 2022, respectively
    		            
      series a+ redeemable convertible preferred shares – 0.0001 par value, 0 and 12,800 shares authorized, issued and outstanding as of march 31, 2023 and december 31, 2022, respectively
    		            
      series b redeemable convertible preferred stock – 0.0001 par value, 0 and 32,857 shares authorized, issued and outstanding as of march 31, 2023 and december 31, 2022, respectively
    		            
      series b‑1 redeemable convertible preferred stock – 0.0001 par value, 0 and 2,161 shares authorized, issued and outstanding as of march 31, 2023 and december 31, 2022, respectively
    		            
      undesignated shares – 0.0001 par value; 100,000 and 0 shares authorized as of march 31, 2023 and december 31, 2022, respectively; no shares issued and outstanding as of march 31, 2023 and december 31, 2022
    		            
      ordinary shares – 0.0001 par value; 500,000 and 432,982 shares authorized as of march 31, 2023 and december 31, 2022, respectively; 114,730 and 10,527 shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively
    		          11,000  
      liabilities, redeemable convertible preferred shares and shareholders’ deficit
    		            
      series a redeemable convertible preferred shares – 0.0001 par value, 19,200 shares authorized, issued and outstanding as of december 31, 2022 and 2021
    		           32,001,000 
      series a+ redeemable convertible preferred shares – 0.0001 par value, 12,800 shares authorized, issued and outstanding as of december 31, 2022 and 2021
    		           26,000,000 
      series b redeemable convertible preferred stock – 0.0001 par value, 32,857 and 24,702 shares authorized, issued and outstanding as of december 31, 2022 and 2021, respectively
    		           133,015,000 
      series b‑1 redeemable convertible preferred stock – 0.0001 par value, 2,161 shares authorized, issued and outstanding as of december 31, 2022 and 2021
    		           8,959,000 
      shareholders’ deficit:
    		            
      ordinary shares – 0.0001 par value; 432,982 and 441,137 shares authorized as of december 31, 2022 and 2021, respectively; 10,527 and 10,894 shares issued and outstanding as of december 31, 2022 and 2021, respectively
    		           1,000 
      total shareholders’ deficit
    		           -115,140,000 
      total liabilities, redeemable convertible preferred shares and shareholders’ deficit
    		           97,845,000 
      operating expenses:
    		            
      research and development
    		           36,193,000 
      general and administrative
    		           16,368,000 
      total operating expenses
    		           52,561,000 
      income from operations
    		           -52,561,000 
      interest and other income
    		           1,257,000 
      income before benefit from income taxes
    		           -51,304,000 
      benefit from income taxes
    		           17,000 
      net income
    		           -51,321,000 
      less: accretion of redeemable convertible preferred shares to their redemption value
    		           -1,515,000 
      less: excess of the fair value of the consideration paid over the carrying value of redeemable noncontrolling interest
    		            
      net income attributable to ordinary shareholders
    		           -52,836,000 
      net income per share
    		           -5,510 
      weighted-average ordinary shares used in computing net income per share attributable to ordinary shareholders, basic and diluted
    		           9,584,000 
      other comprehensive loss:
    		            
      unrealized gain on investments
    		           -110,000 
      total other comprehensive gain
    		           -110,000 
      comprehensive loss
    		           -51,431,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.